The Isosorbide Mononitrate Tablet Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Isosorbide Mononitrate Tablet Market?
The isosorbide mononitrate tablet market has expanded substantially in the past few years. The market size is projected to increase from $1.14 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Isosorbide Mononitrate Tablet Industry?
The Isosorbide Mononitrate Tablet Global Market is anticipated to reach a market size of $1.51 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.6%.
Download Your Free Sample of the 2025 Isosorbide Mononitrate Tablet Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Isosorbide Mononitrate Tablet Market?
The key drivers in the isosorbide mononitrate tablet market are:
• Regulatory approvals and patent expirations are driving the market.
• There's an increasing adoption of generic drugs.
• Growth in lifestyle-related risk factors and government initiatives for cardiovascular disease management are fueling the market.
• Improvements in diagnostic infrastructure and awareness campaigns are key contributors to growth.
Global Market Segmentation: Identifying Major Isosorbide Mononitrate Tablet Industry Segments
The isosorbide mononitrate tablet market covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets
2) By Indication Type: Angina Pectoris, Heart Failure, Hypertension
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Pre-order the 2025 Isosorbide Mononitrate Tablet Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Isosorbide Mononitrate Tablet Market?
The key trends in the isosorbide mononitrate tablet market are:
• Advancements in extended-release formulations are anticipated to shape the market.
• Technological innovations, especially in digital health platforms and e-commerce, are expected to impact the future market.
• The integration of digital health technologies is a significant emerging trend.
• The combination of isosorbide mononitrate with other cardiovascular drugs is emerging as a new potential area in the market.
Who Are the Top Competitors & Leading Players in the Isosorbide Mononitrate Tablet Market?
Major players in the isosorbide mononitrate tablet market are:
• Pfizer Inc.
• Merck & Co. Inc.
• AstraZeneca PLC
• Abbott Laboratories Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.
• Cipla Ltd.
• Zydus Lifesciences Limited
• Recipeharm
• Torrent Pharmaceuticals Ltd.
• Micro Labs Ltd.
• Lotus Pharmaceuticals
• Healthy Inc.
• Qilu Pharmaceutical Co., Ltd
• Lunan Pharmaceutical Group
• Johnlee Pharmaceuticals Pvt. Ltd.
• Niksan Pharmaceutical
• Shandong Keyuan Pharmaceutical
• Prevego Healthcare & Research Private Limited
Regional Dominance: Which Area Leads the Global Isosorbide Mononitrate Tablet Market?
North America was the largest region in the isosorbide mononitrate tablet market in 2024
